Related Experiment Videos
[Hyperlipoproteinemia and the genetic epidemiology of diabetes mellitus]
Insights
Cardiovascular disease is a leading cause of death for type II diabetics. Comprehensive risk factor management and genetic epidemiology aid in early detection and prevention within high-risk families.
Area of Science:
- Cardiology
- Diabetology
- Genetics
Context:
- Cardiovascular diseases (CVD) are the primary cause of mortality in type II diabetes mellitus (T2DM) patients.
- T2DM patients often present with multiple risk factors including hyperlipoproteinemia, hypertension, obesity, hyperuricemia, and smoking.
- Effective primary prevention of CVD in T2DM necessitates concurrent management of all identified risk factors.
Purpose:
- To highlight the critical role of comprehensive risk factor management in preventing cardiovascular disease in type II diabetics.
- To emphasize the utility of genetic epidemiology in identifying and managing at-risk family members of diabetic patients.
- To propose an integrated approach for the primary prevention of cardiovascular disease in high-risk diabetic subpopulations.
Summary:
- Cardiovascular diseases are the leading cause of death in type II diabetics, often exacerbated by co-existing risk factors like hyperlipoproteinemia and hypertension.
- Comprehensive treatment addressing all risk factors is crucial for primary prevention.
- Genetic epidemiology offers a systematic method for early detection and intervention in families, representing a rational preventive strategy for high-risk groups.
Impact:
- Implementing this strategy can significantly reduce cardiovascular mortality in the type II diabetic population.
- Early detection and management of genetic predispositions can lead to more targeted and effective primary prevention efforts.
- This approach facilitates proactive healthcare for individuals and families at elevated risk for cardiovascular complications associated with type II diabetes.
Abstract:
Cardiovascular diseases are the most frequent cause of mortality in the sub-population of type II diabetics (cca 600,000 in the CSSR). Type II diabetics very frequently cumulate several very serious risk factors (hyperlipoproteinaemia, arterial hypertension, obesity, hyperuricaemia, smoking) for the manifestation of cardiovascular disease. Concurrent comprehensive treatment of all revealed risk factors is essential for primary prevention. Systematic application of methods of genetic epidemiology in families of affected diabetics helps to detect in time and to treat other affected members of the family. It is at the same time a rational way of primary prevention of cardiovascular disease in the highest risk sub-populations. The authors submit an algorithm of treatment of hyperlipoproteinaemic type II diabetics.